THYROTROPIN (TSH) AFTER IODINE-131 THERAPY

被引：0
|
作者：
GIBBERD, M [1 ]
MCMILLAN, M [1 ]
STAFFURTH, JS [1 ]
机构：
[1] LEWISHAM HOSP, LONDON SE13 6LH, ENGLAND
来源：
LANCET | 1974年 / 1卷 / 7865期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1048 / 1048
页数：1
相关论文
共 50 条
  • [1] BEWARE OF SUPPRESSED TSH IN IODINE-131 THERAPY!
    Abramowski, E.
    Sivaratnam, D.
    Hassall, S.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 33 - 33
  • [2] THYROID CANCER AFTER IODINE-131 THERAPY
    STARR, P
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 227 (08): : 940 - 940
  • [3] THYROID CANCER AFTER IODINE-131 THERAPY
    MCDOUGALL, IR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 227 (04): : 438 - 438
  • [4] Menstrual cycle disorders after therapy with iodine-131
    Sioka, Chrissa
    Kouraklis, Gregory
    Zafirakis, Athanasios
    Manetou, Angeliki
    Dimakopoulos, Nikolaos
    FERTILITY AND STERILITY, 2006, 86 (03) : 625 - 628
  • [5] Fertility after iodine-131 therapy for thyroid cancer
    Vini, L
    Pratt, B
    Al-Saadi, A
    McCready, VR
    Harmer, C
    BRITISH JOURNAL OF CANCER, 1998, 78 : 16 - 16
  • [6] Menstrual Cycle Disorders after Therapy with Iodine-131
    Sioka, C.
    Zafirakis, A.
    Kouraklis, G.
    Manetou, A.
    Dimakopoulos, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S242 - S242
  • [7] SERUM FTI AND TSH IN IODINE-131 TREATED HYPERTHYROIDISM
    SMYTH, PPA
    ODONOVAN, DK
    LANCET, 1974, 1 (7866): : 1108 - 1108
  • [8] Transient hypothyroidism after iodine-131 therapy for Graves' disease
    Gómez, N
    Gómez, JM
    Villabona, C
    Soler, J
    CLINICAL ENDOCRINOLOGY, 1998, 48 (04) : 526 - 527
  • [9] THYROID ANTIBODIES IN EUTHYROID SUBJECTS AFTER IODINE-131 THERAPY
    EINHORN, J
    FAGRAEUS, A
    JONSSON, J
    RADIATION RESEARCH, 1966, 28 (02) : 296 - &
  • [10] A rare case of iododerma after therapy with oral Iodine-131
    Lazaga, Francisco
    Agarwal, Anshul
    Erdman, William
    Oz, Orhan
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
12345